Shares in Sanofi were sliding today after a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis (MS). Along with what looks set to be ...
U.S. tech companies are known to stockpile as much user data as they can, but DeepSeek's privacy policy makes Meta, Google, and OpenAI look tame. "The personal information we collect from you may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results